Search Results - Jesse H Erasmus
- Showing 1 - 12 results of 12
-
1
Replicating RNA vaccine confers durable immunity against Crimean Congo hemorrhagic fever virus challenge in mice by Shanna S. Leventhal, Carl Shaia, Deepashri Rao, Matthew Lewis, Kimberly Meade-White, Jesse H. Erasmus, Heinz Feldmann, David W. Hawman
Published in npj Vaccines (2024-12-01)Get full text
Article -
2
Single-dose replicon RNA Sudan virus vaccine uniformly protects female guinea pigs from disease by Kyle L. O’Donnell, Hanna Anhalt, Greg Saturday, Nikole L. Warner, Troy Hinkley, E. Taylor Stone, Kiara Hatzakis, Amit P. Khandhar, Logan Banadyga, Jesse H. Erasmus, Andrea Marzi
Published in Nature Communications (2025-05-01)Get full text
Article -
3
An RNA-Based Vaccine Platform for Use against <i>Mycobacterium tuberculosis</i> by Sasha E. Larsen, Jesse H. Erasmus, Valerie A. Reese, Tiffany Pecor, Jacob Archer, Amit Kandahar, Fan-Chi Hsu, Katrina Nicholes, Steven G. Reed, Susan L. Baldwin, Rhea N. Coler
Published in Vaccines (2023-01-01)Get full text
Article -
4
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine by Zachary MacMillen, Kiara Hatzakis, Adrian Simpson, Melanie J. Shears, Felicia Watson, Jesse H. Erasmus, Amit P. Khandhar, Brandon Wilder, Sean C. Murphy, Steven G. Reed, James W. Davie, Marion Avril
Published in npj Vaccines (2024-01-01)Get full text
Article -
5
Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques. by Alexandra C Willcox, Kevin Sung, Meghan E Garrett, Jared G Galloway, Jesse H Erasmus, Jennifer K Logue, David W Hawman, Helen Y Chu, Kim J Hasenkrug, Deborah H Fuller, Frederick A Matsen Iv, Julie Overbaugh
Published in PLoS Pathogens (2022-04-01)Get full text
Article -
6
Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in mice by David W. Hawman, Thomas Tipih, Eddie Hodge, E. Taylor Stone, Nikole Warner, Natalie McCarthy, Brian Granger, Kimberly Meade-White, Shanna Leventhal, Kiara Hatzakis, Stephanie Park, Karen Gaffney, Kyle Rosenke, Jesse H. Erasmus, Heinz Feldmann
Published in Nature Communications (2025-01-01)Get full text
Article -
7
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern by David W Hawman, Kimberly Meade-White, Jacob Archer, Shanna S Leventhal, Drew Wilson, Carl Shaia, Samantha Randall, Amit P Khandhar, Kyle Krieger, Tien-Ying Hsiang, Michael Gale, Peter Berglund, Deborah Heydenburg Fuller, Heinz Feldmann, Jesse H Erasmus
Published in eLife (2022-02-01)Get full text
Article -
8
Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21 by Shanna S. Leventhal, Thomas Bisom, Dean Clift, Deepashri Rao, Kimberly Meade-White, Carl Shaia, Justin Murray, Evan A. Mihalakakos, Troy Hinkley, Steven J. Reynolds, Sonja M. Best, Jesse H. Erasmus, Leo C. James, Heinz Feldmann, David W. Hawman
Published in Nature Communications (2024-10-01)Get full text
Article -
9
Chikungunya Virus as Cause of Febrile Illness Outbreak, Chiapas, Mexico, 2014 by Tiffany F. Kautz, Esteban E. Díaz-González, Jesse H. Erasmus, Iliana R. Malo-García, Rose M. Langsjoen, Edward I. Patterson, Dawn I. Auguste, Naomi L. Forrester, Rosa Maria Sanchez-Casas, Mauricio Hernández-Ávila, Celia M. Alpuche-Aranda, Nikos Vasilakis, Ildefonso Fernández-Salas
Published in Emerging Infectious Diseases (2015-11-01)Get full text
Article -
10
Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine by David W. Hawman, Kimberly Meade-White, Chad Clancy, Jacob Archer, Troy Hinkley, Shanna S. Leventhal, Deepashri Rao, Allie Stamper, Matthew Lewis, Rebecca Rosenke, Kyle Krieger, Samantha Randall, Amit P. Khandhar, Linhue Hao, Tien-Ying Hsiang, Alexander L. Greninger, Michael Gale, Jr, Peter Berglund, Deborah Heydenburg Fuller, Kyle Rosenke, Heinz Feldmann, Jesse H. Erasmus
Published in EBioMedicine (2022-09-01)Get full text
Article -
11
A gH/gL-encoding replicon vaccine elicits neutralizing antibodies that protect humanized mice against EBV challenge by Kristina R. Edwards, Harman Malhi, Karina Schmidt, Amelia R. Davis, Leah J. Homad, Nikole L. Warner, Crystal B. Chhan, Samuel C. Scharffenberger, Karen Gaffney, Troy Hinkley, Nicole B. Potchen, Jing Yang Wang, Jason Price, M. Juliana McElrath, James Olson, Neil P. King, Jennifer M. Lund, Zoe Moodie, Jesse H. Erasmus, Andrew T. McGuire
Published in npj Vaccines (2024-06-01)Get full text
Article -
12
A replicon RNA vaccine can induce durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned. by Megan A O'Connor, David W Hawman, Kimberly Meade-White, Shanna Leventhal, Wenjun Song, Samantha Randall, Jacob Archer, Thomas B Lewis, Brieann Brown, Megan N Fredericks, Kaitlin R Sprouse, Hillary C Tunggal, Mara Maughan, Naoto Iwayama, Chul Ahrens, William Garrison, Solomon Wangari, Kathryn A Guerriero, Patrick Hanley, Jamie Lovaglio, Greg Saturday, David Veesler, Paul T Edlefsen, Amit P Khandhar, Heinz Feldmann, Deborah Heydenburg Fuller, Jesse H Erasmus
Published in PLoS Pathogens (2023-04-01)Get full text
Article
